Posted on Friday, October 21, 2022
On behalf of the American Statistical Association (Boston, Connecticut, Florida,
New Jersey, Princeton/Trenton, and Washington chapters), Boehringer Ingelheim
Pharmaceuticals, Inc. (Biostatistics and Data Sciences Department), and the New
England Statistical Society (NESS), we cordially invite you to the following
webinar:
Topic: A 2-in-1 Adaptive Design to Seamlessly Expand a Selected Dose from a
Phase 2 Trial to a Phase 3 Trial for Oncology Drug Development
Speaker: Dr. Eric Zhang, Associated Director, Biostatistics, BeiGene USA,
Inc.
Abstract: Please see the attached file
Date: Thursday, November 10, 2022
Time: 9:00-10:00 am EST (New York), including 10-minute Q&A
We are co-sponsoring a series of webinars on innovative statistical
methodologies and other related topics. The webinar series is open to the ASA
community and general external audiences.
Please feel free to forward the meeting planner to other
colleagues. For any questions or help regarding joining
the meeting, please send an email to the
following:
MEDecc.US@boehringer-ingelheim.com
with the subject line “I want to attend webinar no.31 on November 10th, please send me the link”.
